Court rules for drugmakers in 340B fight over contract pharmacies
Bio Pharma Dive
JANUARY 31, 2023
The drugmakers sued HHS after regulators ordered them to stop restricting sales of 340B drugs to contract pharmacies. The decision is a win for Sanofi, Novo Nordisk and AstraZeneca.
Let's personalize your content